Mealey's (December 18, 2018, 10:15 AM EST) -- PHOENIX — An Arizona federal judge on Dec. 14 sanctioned opioid maker Insys Therapeutics Inc. for failing to prepare a corporate witness to answer why company emails apparently used an exclamation point instead of the word “cancer” (Blue Cross of California Incorporated, et al. v. Insys Therapeutics Incorporated, No. 17-2286, D. Ariz.)....